14 advisor opinions Base Subscription Required
Aehr Test Systems AI Forecast Summary
Unlock the rating distributions, return ranges and advisor comparison with a Base subscription.
Checking your access...
Browse Free Assets1 Year Ratings & Returns ()
Ratings: 5 Sell All 1 Partial Sell 2 Neutral 6 Strong Buy
Returns range: from -23.1% to +74.6%
5 Year Ratings & Returns ()
Ratings: 6 Sell All 5 Partial Sell 2 Neutral 1 Strong Buy
Returns range: from -61.3% to +128.8%
Calculated from End of Date $53.57
What do advisors disagree on
The decisive disagreement across reports centers on the durability of the current order inflection versus long-term capital equipment cyclicality. Bullish frameworks view initial artificial intelligence and optical interconnect wins as the start of a multi-year secular compounding monopoly, justifying premium forward multiples. Conversely, value-oriented and forensic perspectives argue that current orders represent front-loaded factory tooling that will inevitably trigger a post-ramp capacity digestion lull. Resolving this tension requires observing sequential quarterly bookings through fiscal 2027: sustained non-lead customer expansion confirms secular adoption, whereas book-to-bill ratios falling below parity confirms cyclical tooling digestion.
Compare all 14 opinions1 Year & 5 Year ratings, targets & returns · Sorted by 5 Year price return
| Advisor | Model | Research | 1 Year | 5 Year | Full Report | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Target date | Rating | Price target | Price return | Target date | Rating | Price target | Price return | ||||
| Universal Investor AI The Polymath Framework | Claude Opus 5 | Researcher Mode with Web Search Used | $93.54 | +74.6% | $122.59 | +128.8% | Full report | ||||
| Superintelligence AI The Anthropologist Framework | Gemini 3.8 Flash | Researcher Mode with Web Search Used | $69.17 | +29.1% | $65.91 | +23.0% | Full report | ||||
| Universal Investor AI The Polymath Framework | GPT-6 Astra | Researcher Mode with Web Search Used | $66.79 | +24.7% | $63.90 | +19.3% | Full report | ||||
| Elon Musk AI The Visionary Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $51.61 | -3.7% | $54.72 | +2.1% | Full report | ||||
| Universal Investor AI The Polymath Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $64.03 | +19.5% | $53.27 | -0.6% | Full report | ||||
| Ray Dalio AI The Strategist Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $66.86 | +24.8% | $51.12 | -4.6% | Full report | ||||
| Niccolo Machiavelli AI The Insider Framework | Gemini 3.8 Flash | Researcher Mode with Web Search Used | $42.75 | -20.2% | $48.90 | -8.7% | Full report | ||||
| J.P. Morgan AI The Titan Framework | Gemini 3.8 Flash | Researcher Mode with Web Search Used | $54.13 | +1.0% | $47.78 | -10.8% | Full report | ||||
| Sherlock Holmes AI The Whistleblower Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $64.71 | +20.8% | $44.27 | -17.4% | Full report | ||||
| Warren Buffett AI The Value Seeker Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $43.79 | -18.3% | $40.88 | -23.7% | Full report | ||||
| Warren Buffett AI The Value Seeker Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $55.33 | +3.3% | $39.13 | -27.0% | Full report | ||||
| Michael Burry AI The Vulture Framework | Gemini 3.8 Flash | Researcher Mode but Web Search Wasn't Used | $41.17 | -23.1% | $35.31 | -34.1% | Full report | ||||
| Universal Investor AI The Polymath Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $49.32 | -7.9% | $33.83 | -36.8% | Full report | ||||
| Superintelligence AI The Anthropologist Framework | Gemini 3.8 Flash | Thinker Mode with Web Search Disabled | $54.89 | +2.5% | $20.72 | -61.3% | Full report | ||||
Prices, dates & return assumptions
1 Year and 5 Year identify the original published checkpoints. Current returns compare the dated close with each fixed target over its remaining horizon. Original quarterly tables use the publication-time anchor. Targets and observed prices share a split-adjusted basis.
Ratings use the shared volatility-adjusted calculation.
Ranges and rating distributions use matching currencies, price bases and target dates. Missing or expired checkpoints are excluded; targets are never extrapolated. Shared frameworks and models can produce correlated opinions.
Aehr Test Systems Stock Analysis & Forecast — Universal Investor The Polymath Framework on Claude Opus 5 Model
Universal Investor AI · The Polymath Framework
5 Year Rating
5 Year Price Return
+128.8%
Framework Description & Key Record Dates
Investment Framework
The Polymath Framework: Eight-Lens Investment Analysis Framework
Analysis Framework Description: Select the lenses with the greatest explanatory power, resolve their disagreements across horizons, and connect the evidence to a consistent thesis, scenario path, and verdict.
- Ownership and value: examine economic rights, competitive advantage, capital allocation, and the price paid.
- Regimes and constraints: connect credit, liquidity, policy, demand, and physical bottlenecks to the asset.
- Innovation and adaptation: test adoption economics, AI and robotics exposure, substitution, and value capture.
- Forensics and incentives: reconcile accounting, cash conversion, dilution, governance, and missing evidence.
- Expectations and reflexivity: distinguish changes in fundamentals from changes in narratives and valuation.
- Probabilities and resilience: use base rates, competing scenarios, catalysts, and the capacity to survive the wait.
- Power and the rules of the game: assess political interests, regulatory influence, protection, and dependency.
- Industry structure and consolidation: identify pricing power, chokepoints, alliances, and the economics of integration.
- Model Producer:
- Anthropic
- Model Version:
- Claude Opus 5
- Mode Used:
- Researcher
- Input Data:
- Input records not available
- Forecast Target Date:
- Latest Known Price Date for Return Estimate Refresh:
- Forecast Published On:
- Forecast Generated On:
- Model knowledge cutoff:
- Supplied Context Data, Prices & Events Cutoff:
- Not recorded
Return calculation details
Current returns use the observed price and remaining time to the fixed published target. The quarterly table retains the original forecast anchor.
Full advisor report Chart, analysis, and sources
Aehr Test Systems: Historical Prices & Published Forecast
Analyzed by The Polymath Framework using the Opus 5 model
- Observed price
- Published advisor forecast
Aehr Test Systems: Quarterly Price Forecasts & Scenarios
Analyzed by The Polymath Framework using the Opus 5 model
Price targets, price returns and complete scenario reasoning
Forecast prices in USD. Price returns are cumulative from the original forecast anchor dated 2026-09-18; they exclude dividends. Swipe horizontally to read every column.
| Quarter | Forecast | Price return | Scenario |
|---|---|---|---|
| $84.1 | -10.0% | The first-quarter fiscal 2027 print between October 5 and 12 tests backlog conversion. Revenue accelerates but gross margin near the mid-thirties disappoints euphoric positioning while the ten-year near 5% compresses a 56x sales multiple. | |
| $95.9 | +2.6% | Shipments of the $22M AI processor order land at the Taiwanese manufacturing partner, revenue roughly doubles year over year, and January guidance reaffirms the $130-150M range. Momentum capital returns after the autumn reset. | |
| $102 | +8.8% | Silicon-photonics and optical-interconnect follow-on shipments sustain sequential growth, but heavier system mix keeps gross margin below forty percent. Gains track delivered earnings rather than any further multiple expansion in a restrictive rate regime. | |
| $93.5 | +0.1% | Fiscal 2027 results confirm roughly $140M of revenue and the first profitable year, yet the initial fiscal 2028 guide implies deceleration from a drawn-down backlog. Expectations reset lower despite the operational win. | |
| $87.9 | -5.9% | Accelerator customers digest 2027 capacity additions, bookings turn lumpy and one hyperscaler defers a qualification slot. Persistent policy restriction keeps discount rates elevated, so a still-expensive multiple contracts further into year-end. | |
| $96.7 | +3.5% | New packaged-part burn-in wins for custom ASICs restore bookings growth while WaferPak consumable revenue rises with a tripled installed base. Improving mix lifts gross margin and rebuilds confidence in operating leverage. | |
| $102 | +8.6% | Steady conversion of a rebuilt backlog delivers mid-teens revenue growth, and the expanded Fremont capacity absorbs volume without capital intensity. Solid execution supports the price without triggering any valuation step-change. | |
| $108 | +15.1% | Fiscal 2028 results show gross margin recovering toward the low forties as consumables mix improves. The market rewards visible proof that revenue scale finally converts into durable earnings per share. | |
| $98.0 | +4.8% | A semiconductor equipment down-leg arrives as hyperscaler capex growth normalises. Extreme customer concentration amplifies the drawdown when a single deferred production order removes roughly a quarter of consensus revenue. | |
| $105 | +12.1% | Order recovery led by high-bandwidth memory evaluation and co-packaged optics screening. Management reinstates guidance after the air pocket, and the shares recover part of the cyclical discount applied three months earlier. | |
| $109 | +16.6% | Installed-base consumable revenue now cushions system lumpiness, producing steadier quarterly results. Modest appreciation reflects compounding earnings against a multiple still deflating from its 2026 speculative peak toward sector norms. | |
| $104 | +10.8% | Fiscal 2029 results reveal pricing pressure as incumbent test vendors bundle burn-in into integrated cells. Gross margin guidance trims, and investors mark down the sole-vendor premium embedded since 2026. | |
| $112 | +19.6% | A large qualification win in packaged-part burn-in for next-generation accelerators restores the growth narrative. Easier monetary conditions by this point lift the discount rate constraint on long-duration semiconductor equipment valuations. | |
| $115 | +23.2% | Revenue growth settles into the twenties percent range with stable low-forties gross margin. The equity behaves like a maturing semiconductor capital-equipment name rather than a speculative AI derivative. | |
| $107 | +14.6% | Competitive test-cell launches from an established vendor pressure win rates at a second-tier account. Guidance held flat sequentially, and the market discounts the durability of Aehr's contactor-based advantage. | |
| $114 | +21.5% | Fiscal 2030 results show consumables approaching a third of revenue, structurally improving mix and cash conversion. Investors reward recurring economics that reduce the historic feast-and-famine quarterly pattern. | |
| $118 | +26.3% | Advanced packaging complexity keeps screening demand growing, and free cash flow turns consistently positive without further equity issuance. Steady compounding replaces narrative as the driver of the share price. | |
| $120 | +28.9% | A mature, profitable equipment franchise trades on earnings rather than stories. Incremental appreciation tracks modest guidance raises, with the share count now stable after the at-the-market programme lapses unused. | |
| $116 | +23.7% | A mid-cycle inventory correction across semiconductor test equipment trims bookings for two quarters. Concentration again amplifies the move, though a net-cash balance sheet limits the depth of the drawdown. | |
| $123 | +31.1% | Fiscal 2031 closes with revenue near $400M and high-twenties operating margin, validating the long thesis on fundamentals. Persistent strategic-acquisition speculation adds a modest premium to the closing quarter. |
Show remaining 18 quartersShow first 2 quarters only
All 20 quarters are displayed in the table above.
Aehr Test Systems: Investment Thesis Base Case
Analyzed by The Polymath Framework using the Opus 5 modelThe central tension is not whether revenue triples — backlog, named orders and guidance make that probable — but whether gross margin and share count let the tripling reach the shareholder. Base case: fiscal 2027 lands near $140M, the first profitable year since 2024 arrives, and gross margin recovers into the low forties rather than back to 49%. Earnings growth is then real but slower than the multiple assumes, so the share price advances modestly while the valuation deflates toward the fundamentals. Investors earn business growth, not rerating, and endure violent quarterly swings to collect it.
- Fiscal 2027 revenue of $130-150M against a $2.87B market capitalisation implies roughly 20x forward sales.
- Sustaining today's price requires about $3.00 earnings per share by fiscal 2031 on a 30x multiple.
- Cross-check: $400M revenue at 25% net margin across 33 million shares produces exactly that per-share outcome.
Aehr Test Systems: Scenarios & Signals
Analyzed by The Polymath Framework using the Opus 5 modelBull Case
The bull case activates if gross margin snaps back above 45% while bookings keep compounding — margin recovery and order growth must arrive together, not sequentially. Then $150M of fiscal 2027 revenue drops far more to operating income than modelled, the installed base doubles WaferPak consumable revenue, and a memory or co-packaged-optics qualification extends the addressable market. Operating leverage plus a widened moat justifies a premium multiple on genuinely larger earnings, and the shares compound well past $180.
Bear Case
The bear case activates when one lead customer defers and gross margin stays in the thirties simultaneously. Revenue misses the $130M floor, the operating-leverage story collapses into a second consecutive loss year, and the at-the-market programme is tapped again from a lower price — diluting holders precisely when the narrative premium evaporates. With a 5% risk-free rate anchoring discount rates, a 56x sales multiple has nowhere to rest. The shares could halve without any change in long-term technology logic.
Behavioral Alpha Signals
Sentiment, repricing cycle, crowd narrative, catalyst, and macro alignment.Expected Volatility Regime: High
Greed and Fear Index: +55 / 100 (Greed)
Cycle Position: Overshoot
Speculation has pushed the narrative beyond fundamentals.
What does Media Tell? (Crowd Consensus)
The settled belief is that Aehr has become the toll booth on AI burn-in, and that $100.6M of effective backlog plus 160-200% guided growth are already banked revenue. A 327% year-to-date run, Jefferies at $175 and a September Oppenheimer initiation reinforce it . The anchor is the booking number; almost nobody anchors on gross margin falling to 35.3%.
What Crowds Get Wrong? (Alpha/Value Gap)
The crowd overestimates what these shares are worth: the inflection is real but fully paid for. The overlooked evidence is arithmetic, not narrative — fourteen points of gross-margin erosion since fiscal 2024 alongside roughly $100M of at-the-market issuance means a tripled top line reaches materially fewer dollars per share than a 56x sales multiple assumes . Sustaining $93.50 requires near-flawless execution to roughly $400M of revenue at semiconductor-leader margins by fiscal 2031. That is a forecast, not a floor.
When will Value Gap Repricing Happen? (Repricing Catalyst)
The first-quarter fiscal 2027 print, estimated between October 5 and 12, 2026, is the recognition event . It is the first disclosure where backlog conversion and gross margin appear together on one page. The first observable sign of repricing will be the margin line, not the revenue headline.
How is Asset Influenced by Macro Regime?
The macro wind is in its face on valuation and at its back on demand. A 4.998% ten-year Treasury and a Fed at 3.75%-4.00% compress precisely the long-duration, pre-profit equities this is [fedsept]. Meanwhile AI infrastructure capex, the sole demand channel that matters here, remains the strongest spending stream in the economy.
Aehr Test Systems: Positive & Negative Factors, Risks & Opportunities
Analyzed by The Polymath Framework using the Opus 5 modelBase-Case Forces
Top Drivers / Tailwinds
Base-case positive forces
Structural or operating forces that support this advisor thesis. Base-case means above 70% probability of occurrence. Probabilities are model estimates; unquantified forces retain their published group.
Scroll to view all columns
| Driver / Tailwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| ONLY Vendor Holding BOTH BURN IN Modalit | Competitive Positioning | +42% | +180% | Aehr is the sole supplier pairing wafer-level burn-in with Incal-derived ultra-high-power packaged-part systems, and the order book proves customers pay for that breadth: a record $41M hyperscaler ASIC order and a $22M follow-on from the lead AI processor customer lifted effective backlog to $100.6M at fiscal year-end . That breadth underwrites fiscal 2027 guidance of $130-150M and persists until incumbents field an equivalent dual stack. |
| Expensive AI Packages MAKE Screening COM | Sector And Industry | +35% | +150% | As accelerator packages stack HBM, interface logic and compute onto one substrate, the cost of discovering an infant-mortality die after assembly rises superlinearly, which turns pre-singulation screening from optional into economically compulsory . That arithmetic, not marketing, explains why a networking customer moved from first engagement to volume production within seven months . Demand persists while advanced-package value per unit keeps climbing through the decade. |
| Waferpak Consumables ARE THE REAL Annuit | Innovation And Product | +22% | +70% | The tester chassis is the razor; the device-specific WaferPak contactor and DiePak carrier are the blades. Designing reliable high-current contactors demands years of empirical materials-science data, which is the genuinely defensible asset rather than the system frame . As the installed base expands with fiscal 2027 shipments, attached consumable revenue should improve mix quality, smooth the lumpy system cycle and raise the floor under gross margin. |
| Capital Light Scaling ON A Fortress BALA | Capital Allocation | +15% | +40% | Capital expenditure was only $2.1M in fiscal 2026 against a revenue base management expects to roughly triple, so incremental volume consumes working capital rather than plant . Cash, equivalents and restricted cash of $116.5M at May 29, 2026 removes financing risk while the ten-year Treasury sits near 5% . Growth therefore reaches shareholders through operating leverage instead of interest expense or distress financing. |
Top Frictions / Headwinds
Base-case negative forces
Expected frictions that can slow, cap, or damage this advisor thesis. Base-case means above 70% probability of occurrence. Probabilities are model estimates; unquantified forces retain their published group.
Scroll to view all columns
| Friction / Headwind | Category | Est. stock-price impact | Est. earnings impact | Why it matters |
|---|---|---|---|---|
| A FIVE Percent Discount RATE Meets 56x S | Macroeconomic And Macrofinancial | -38% | +0.0% | At $93.50 the equity capitalises 56x trailing sales and roughly 20x the top of fiscal 2027 guidance, on a business that consumed $3.3M of operating cash last year . With the Fed at 3.75%-4.00% and the ten-year Treasury at 4.998% on September 18, long-duration cash flows are discounted harder every quarter. Multiple compression, not order failure, is the single likeliest source of drag. |
| Gross Margin Bleeding Through THE AI PIV | Operational Efficiency | -24% | -45% | Gross margin fell from 49.1% in fiscal 2024 to 40.6%, then 35.3% in fiscal 2026 — fourteen points of erosion precisely as the AI mix arrived. If large-system and packaged-part revenue structurally carries lower margin, tripling revenue toward $140M delivers far less earnings per share than the revenue multiple assumes. This is the decisive undisclosed variable; only sustained recovery above 45% validates the operating-leverage case. |
| Three Customers Carry THE Entire Backlog | Competitive Positioning | -20% | -30% | The lead AI processor, lead hyperscale and lead silicon-photonics accounts carry nearly all bookings, and shipments install at a Taiwanese manufacturing partner inside an active tariff and export-control regime . A single qualification loss or deferred capacity decision removes a quarter of forecast revenue. Fiscal 2026 already demonstrated the pattern: bookings converted into revenue with both a lag and a haircut. |
| Dilution Bought THE Fortress | Management And Governance | -14% | -8.0% | Roughly $100M was raised through the at-the-market programme during fiscal 2026, which explains equity rising from $123M to $220M while the company reported a $7.1M loss . Shareholders purchased that balance sheet; operations did not earn it. Founder Posedel sold about $1.77M of stock and insiders were net sellers over the trailing year . Management treats an elevated price as funding currency, so further issuance is likely. |
Risks & Opportunities
Top Risks / Downside Scenarios
Lower-probability downside scenarios outside the base-case forecast.
Unlock the risk analysis
Sign in with eligible access to read risks, opportunities and the remaining advisor reports.